Trulieve announces the opening of its Philadelphia subsidiary, Chamounix Ventures, LLC


TALLAHASSEE, Florida., January 7, 2022 / PRNewswire / – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top performing cannabis company in The United States, today announced the opening of a new Trulieve branded medical marijuana dispensary through its subsidiary Chamounix Ventures, LLC. The pharmacy at 1222 Arch St. is on City center Section of Philadelphia. This location will be the company’s 160th owned, operated or affiliated pharmacy nationwide.

Located in the heart of Philadelphia, between City Hall and Reading Terminal Market, the pharmacy is open Monday through Saturday 9 am8 p.m. and on Sunday from 10 am6 p.m.. Patients can choose from Trulieve’s selection of premium whole flower products, including the TruFlower and Cultivar Collection, as well as a wide range of vapes, tinctures, topicals and ingestible products.

“We are proud to start the New Year by demonstrating our continued commitment to the service Pennsylvania Patient community through high quality and reliable medical marijuana products, ”said Kim Rivers, CEO of Trulieve. “We look forward to welcoming patients to this cornerstone market and strengthening community connections.”

Other Trulieve affiliated pharmacies in Pennsylvania are located in Camp Hill, Cranberry Township, Devon, Harrisburg, Johnstown, King of Prussia, Pittsburgh, reading, Scranton, Washington, Whitehall, York and Selienopel.

To find a location or to learn how to become a Registered Patient, visit, follow us on Instagram at trulieve_pa, or connect with Trulieve PA on Facebook.

About Trulieve
Trulieve is an industry-leading vertically integrated cannabis company and multi-state operator in the United States with operations in 11 states and leading positions in Arizona, Florida, and Pennsylvania. Ready for accelerated growth and expansion, Trulieve is expanding the size of retail and distribution in new and existing markets through its hub strategy. By delivering innovative, high quality products across the brand portfolio, Trulieve delivers the best customer experiences and improves access to cannabis, helping patients and customers live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. More information is available at

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor contact
Christine Hersey, Director of Investor Relations
+1 (424) 202-0210
[email protected]

Media contact
Rob Kremer, Managing Director for Corporate Communications
+1 (404) 218-3077
[email protected]

MATTIO communication
[email protected]

Cision View original content to download multimedia:

SOURCE Trulieve Cannabis Corp.